Home therapy with recombinant interleukin-2 and interferon-$alpha;2b in advanced human malignancies
- 1 June 1990
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 335 (8704) , 1509-1512
- https://doi.org/10.1016/0140-6736(90)93039-r
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Combination therapy with interleukin-2 and alpha-interferon for the treatment of patients with advanced cancer.Journal of Clinical Oncology, 1989
- Concomitant administration of recombinant human interleukin-2 and recombinant interferon alpha-2A in cancer patients: a phase I study.Journal of Clinical Oncology, 1989
- Cardiorespiratory effects of immunotherapy with interleukin-2.Journal of Clinical Oncology, 1989
- Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic MelanomaNew England Journal of Medicine, 1988
- PHASE-I TRIAL OF RECOMBINANT INTERLEUKIN-2 AND CYCLOPHOSPHAMIDE - AUGMENTATION OF CELLULAR-IMMUNITY AND T-CELL MITOGENIC RESPONSE WITH LONG-TERM ADMINISTRATION OF RIL-21988
- New Approaches to the Immunotherapy of Cancer Using Interleukin-2Annals of Internal Medicine, 1988
- Metastatic Renal Cancer Treated with Interleukin-2 and Lymphokine-Activated Killer CellsAnnals of Internal Medicine, 1988
- Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced CancerNew England Journal of Medicine, 1987
- Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin 2.The Journal of Immunology, 1986
- T Cell Growth Factor: Parameters of Production and a Quantitative Microassay for ActivityThe Journal of Immunology, 1978